Feedback / Questions
JS014 - Shanghai Junshi Biosci, Anwita Biosci
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT05296772
Nov 23, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next